Brandes Investment Partners LP Increases Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Brandes Investment Partners LP lifted its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 67.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 86,478 shares of the medical instruments supplier's stock after buying an additional 34,776 shares during the period. Brandes Investment Partners LP's holdings in DENTSPLY SIRONA were worth $1,641,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of the company. Janney Montgomery Scott LLC grew its position in DENTSPLY SIRONA by 45.4% during the third quarter. Janney Montgomery Scott LLC now owns 43,203 shares of the medical instruments supplier's stock valued at $1,169,000 after buying an additional 13,491 shares during the period. Venturi Wealth Management LLC grew its position in shares of DENTSPLY SIRONA by 4,893.5% during the 3rd quarter. Venturi Wealth Management LLC now owns 2,297 shares of the medical instruments supplier's stock valued at $62,000 after acquiring an additional 2,251 shares during the period. KBC Group NV increased its stake in shares of DENTSPLY SIRONA by 19.9% in the 3rd quarter. KBC Group NV now owns 6,274 shares of the medical instruments supplier's stock worth $170,000 after purchasing an additional 1,040 shares in the last quarter. Empowered Funds LLC purchased a new stake in shares of DENTSPLY SIRONA in the 3rd quarter worth $2,468,000. Finally, Natixis Advisors LLC raised its holdings in DENTSPLY SIRONA by 21.1% in the 3rd quarter. Natixis Advisors LLC now owns 21,733 shares of the medical instruments supplier's stock worth $588,000 after purchasing an additional 3,787 shares during the period. Institutional investors own 95.70% of the company's stock.

Remove Ads

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY traded down $0.06 during mid-day trading on Thursday, reaching $15.60. The stock had a trading volume of 2,363,338 shares, compared to its average volume of 2,957,948. The business's 50 day moving average price is $18.10 and its 200 day moving average price is $20.67. DENTSPLY SIRONA Inc. has a 1 year low of $14.78 and a 1 year high of $33.72. The company has a market cap of $3.10 billion, a P/E ratio of -7.54, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.10%. DENTSPLY SIRONA's dividend payout ratio is currently -14.07%.

Insider Activity at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier acquired 15,142 shares of the stock in a transaction on Monday, March 3rd. The stock was acquired at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the transaction, the director now directly owns 81,971 shares of the company's stock, valued at $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.52% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Mizuho cut their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a research note on Thursday, March 13th. UBS Group decreased their target price on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating on the stock in a research note on Tuesday, December 3rd. StockNews.com lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Friday, February 28th. Finally, Evercore ISI restated an "in-line" rating and set a $20.00 price objective on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Twelve research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $23.33.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.